BVF Partners
Biotech Investor · 4 portfolio companies
Portfolio
4
Combined Value
$9.8B
Focus Areas
8
Top Stage
Phase 2
Investment Focus
Portfolio Companies
| Company | Valuation |
|---|---|
| Structure Therapeutics | $3.4B |
| NewAmsterdam Pharma Company | $3.3B |
| Relay Therapeutics | $1.8B |
| Olema Pharmaceuticals | $1.2B |